Replies to post #242322 on Biotech Values

[ciotera]

Viekira pak?

[Whalatane]

Ha. So KZR is now a pure play on their Lupus Nephritis drug .
P2 results in June 2022
Trial fails and Co trades at cash on hand .
Trial succeeds and PPS probably doubles
There's your June binary event

Heres someone that can't be happy tonite ...but will hopefully have a better June

http://archive.fast-edgar.com/20220322/AIZIS22C3M22GJK222222ZZ29DCUZ22S4242/

Kiwi

[DewDiligence]

PHAT—(-25%/AH)—discloses that its NDA for vonoprazan monotherapy in erosive esophagitis is
in limbo due to nitrosamine contamination:

https://finance.yahoo.com/news/phathom-pharmaceuticals-provides-drug-application-210100715.html

The PDUFA date had been 1/11/23.